{"a":[{"_":"AAIC: Roche ‘very interested’ in testing tau for Alzheimer’s despite focus on phase 3-stage amyloid drug","$":{"href":"/biotech/aaic-roche-very-interested-tau-despite-focus-phase-3-amyloid-alzheimers-asset","hreflang":"en"}}]}

Summary

Roche expressed interest in testing tau-targeting therapies for Alzheimer's disease while maintaining focus on its phase 3-stage amyloid drug program. The statement indicates the company is exploring multiple mechanisms of action in the Alzheimer's space.